Cargando…

Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy

BACKGROUND: Cancer patients often receive multiple drugs to maximize their therapeutic benefit, treat co-morbidities and counter the adverse effects of chemotherapy. Concomitant administration of multiple drugs increases the risk of drug interactions leading to compromised therapeutic efficacy or sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ismail, Mohammad, Khan, Sehrash, Khan, Fahadullah, Noor, Sidra, Sajid, Hira, Yar, Shazia, Rasheed, Irum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168989/ https://www.ncbi.nlm.nih.gov/pubmed/32307008 http://dx.doi.org/10.1186/s12885-020-06855-9

Ejemplares similares

Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety
por: Noor, Sidra, et al.
Publicado: (2019)

Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study
por: Khan, Qasim, et al.
Publicado: (2017)

Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study
por: Ali, Zahid, et al.
Publicado: (2020)

Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?
por: Noor, Sidra, et al.
Publicado: (2019)

Potential drug–drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria
por: Noor, Sidra, et al.
Publicado: (2020)

Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study
por: Ismail, Mohammad, et al.
Publicado: (2018)

Prevalence of Multi-Drug Resistant Mycobacterium Tuberculosis in Khyber Pakhtunkhwa – A High Tuberculosis Endemic Area of Pakistan
por: ALI, SAJID, et al.
Publicado: (2020)

A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs
por: Koni, Amer A., et al.
Publicado: (2022)

Potential statin-drug interactions: prevalence and clinical significance
por: Zhelyazkova-Savova, Maria, et al.
Publicado: (2014)

Renal drug transporters and their significance in drug–drug interactions
por: Yin, Jia, et al.
Publicado: (2016)

Cell Surface Binding and Lipid Interactions behind Chemotherapy-Drug-Induced Ion Pore Formation in Membranes
por: Ashrafuzzaman, Md., et al.
Publicado: (2021)

Prevalence and Clinical Significance of Drug–Drug and Drug–Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece
por: Spanakis, Marios, et al.
Publicado: (2021)

Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022
por: Khan, Husain Yar, et al.
Publicado: (2023)

Drug-drug interactions in atrial fibrillation patients receiving direct oral anticoagulants
por: Lee, Ji Yun, et al.
Publicado: (2021)

Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy
por: Marcath, Lauren A., et al.
Publicado: (2021)

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
por: Létinier, Louis, et al.
Publicado: (2019)

The prevalence and predictors of herb-drug interactions among Iranian cancer patients during chemotherapy courses
por: Bazrafshani, Maliheh Sadat, et al.
Publicado: (2023)

Assessment of potential drug–drug interactions and its associated factors in the hospitalized cardiac patients
por: Murtaza, Ghulam, et al.
Publicado: (2016)

Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction
por: Siriangkhawut, Methira, et al.
Publicado: (2017)

Prevalence of potential drug-drug interactions in Swedish pediatric outpatients
por: Holm, Johan, et al.
Publicado: (2019)

2-(1H-Indol-3-yl)acetohydrazide
por: Sidra, Lala Rukh, et al.
Publicado: (2012)

Assessment of Adverse Drug Events, Their Risk Factors, and Management Among Patients Treated for Multidrug-Resistant TB: A Prospective Cohort Study From Pakistan
por: Khan, Farman Ullah, et al.
Publicado: (2022)

How fear of intimacy affects infertile men’s neuropsychological functioning through mental toughness
por: Hassan, Sajid, et al.
Publicado: (2023)

Pattern and impact of drugs targeted toward toxicity amelioration in patients receiving cancer chemotherapy
por: Singh, Shruti, et al.
Publicado: (2018)

Honey: Single food stuff comprises many drugs
por: Khan, Shahid Ullah, et al.
Publicado: (2018)

Prevalence of the Prescription of Potentially Interacting Drugs
por: Tragni, Elena, et al.
Publicado: (2013)

A Data-Driven Medical Decision Framework for Associating Adverse Drug Events with Drug-Drug Interaction Mechanisms
por: Noor, Adeeb
Publicado: (2022)

Characterisation of drug-resistant Mycobacterium tuberculosis mutations and transmission in Pakistan
por: Napier, Gary, et al.
Publicado: (2022)

Epidemiology of potential drug-drug interactions in elderly population admitted to critical care units of Peshawar, Pakistan
por: Shakeel, Faisal, et al.
Publicado: (2018)

The Effect of Berberine, a Drug From Chinese Folk Medicine, on Serum and Urinary Uric Acid Levels in Rats With Hyperuricemia
por: Naz, Hira, et al.
Publicado: (2021)

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs
por: van Leeuwen, R W F, et al.
Publicado: (2013)

Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs
por: Imam, Faisal, et al.
Publicado: (2020)

The Prevalence of Mycobacterium tuberculosis Infection Among Cancer Patients Receiving Chemotherapy in a Tertiary Care Center
por: Aldabbagh, Mona A, et al.
Publicado: (2022)

Irrational use of antimalarial drugs in rural areas of eastern Pakistan: a random field study
por: Khan, Shafaat Yar, et al.
Publicado: (2012)

Prevalence and Correlates of Drug-drug Interactions in the Regional Hospital of Gjilan, Kosovo
por: Shabani, Driton, et al.
Publicado: (2014)

Clinically significant drug interactions between antiretroviral and co-prescribed drugs in HIV infected patients: retrospective cohort study
por: Al Sayed, Hawra Ali Hussain, et al.
Publicado: (2022)

Prevalence of Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large Kenyan Cohort
por: Kigen, Gabriel, et al.
Publicado: (2011)

The Prevalence of the Potential Drug-Drug Interactions Involving Anticancer Drugs in China: A Retrospective Study
por: WANG, Weilan, et al.
Publicado: (2019)

Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study
por: Akbar, Zarka, et al.
Publicado: (2021)

Evaluation of Potential Disease‐Mediated Drug–Drug Interaction in Patients With Moderate‐to‐Severe Atopic Dermatitis Receiving Dupilumab
por: Davis, John D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_prbh5da7e7qs6otm67j7irum8g